BofA Securities Downgrades HOOKIPA Pharma Inc. (HOOK) to Underperform

BofA Securities analyst Ying Huang downgraded HOOKIPA Pharma Inc. (NASDAQ: HOOK) from Buy to Underperform with a price target of $0.50 (from $6.00).

For an analyst ratings summary and ratings history on HOOKIPA Pharma Inc. click here. For more ratings news on HOOKIPA Pharma Inc. click here.

Shares of HOOKIPA Pharma Inc. closed at $1.00 yesterday.

You May Also Be Interested In

• A 150% rally in Peloton (PTON) off lows prompts analysts to downgrade stock
• DIC Corp (4631:JP) PT Lowered to JPY3,000 at Morgan Stanley
• Britannia Industries Ltd (BRIT:IN) PT Raised to INR4,874 at Morgan Stanley